Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law Oral Peptides: FAQs on Bioavailability, Safety, and Clinical Use AJMC FDA Set to Review Peptide Access for Compounding Pharmacies Drug Topics oral bpc 157 review BPC 157 TB 500 Caps The internet says BPC 157 is banned the FDA says something more nuanced. At Moonshot Medical in Park Ridge, IL, we provide honest, current guidance on peptide therapy through licensed compounding pharmacies. The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step